이상반응 보고
| VAERS ID | 1627163 |
|---|---|
| 성별 | 여성 |
| 나이 | 14세 |
| 주 코드 | SC |
| 제약회사 | MODERNA |
| 로트 번호 | 005C21A |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-06-10 |
| 발병일 | 2021-06-10 |
| 상태 | 회복 |
증상
- 예방 접종 부위 통증(Vaccination site pain)
- 부적절한 연령의 환자에게 투여된 제품(Product administered to patient of inappropriate age)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
soreness on the vaccination site; first dose of the Moderna Covid-19 Vaccine administered to a 14 year old patient; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness on the vaccination site) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (first dose of the Moderna Covid-19 Vaccine administered to a 14 year old patient) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no.
005C21A) for COVID-19 vaccination.
No Medical History information was reported.
On 10-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.
On 10-Jun-2021, the patient experienced VACCINATION SITE PAIN (soreness on the vaccination site) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (first dose of the Moderna Covid-19 Vaccine administered to a 14 year old patient).
At the time of the report, VACCINATION SITE PAIN (soreness on the vaccination site) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (first dose of the Moderna Covid-19 Vaccine administered to a 14 year old patient) had resolved.
The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Treatment information was not provided.